Tenon Medical, Inc.
For the period ended Aug 13, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 13, 2026 · Filed Aug 13, 2026
Use the contents to explore the available documents and sections.
TNON$1.640.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (In thousands, except per share data)
(In thousands, except per share data)
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $1,279 | $564 | $2,658 | $1,290 |
| Cost of sales | 465 | 319 | 899 | 722 |
| Gross Profit | 814 | 245 | 1,759 | 568 |
| Operating Expenses | ||||
| Research and development | 768 | 503 | 1,430 | 1,194 |
| Sales and marketing | 1,869 | 1,119 | 3,727 | 2,766 |
| General and administrative | 1,531 | 1,480 | 3,236 | 3,142 |
| Total Operating Expenses | 4,168 | 3,102 | 8,393 | 7,102 |
| Loss from Operations | (3,354) | (2,857) | (6,634) | (6,534) |
| Other Income (Expense) | ||||
| Gain on investments | 24 | 88 | 49 | 149 |
| Interest expense | (852) | — | (1,028) | — |
| Other income | 132 | — | 87 | — |
| Total Other Income (Expense), net | (696) | 88 | (892) | 149 |
| Net Loss and Comprehensive Loss | $(4,050) | $(2,769) | $(7,526) | $(6,385) |
| Net Loss Per Share of Common Stock | ||||
| Basic and diluted | $(12.35) | $(12.76) | $(23.16) | $(39.91) |
| Weighted-Average Shares of Common Stock Outstanding | ||||
| Basic and diluted | 328 | 217 | 325 | 160 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.